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Terpenoids represent the most diverse family of natural compounds with up to about 50,000 members including many physiologically important ones [1] . The 2-methyl-D-erythritol-4-phosphate (MEP, 1) pathway is a new biosynthetic route for terpenoids in which 1 and 1-deoxy-D-xylulose-5-phosphate (DXP, 2) are the key intermediates. Compound 2 is synthesized from D-glyceraldehyde-3-phosphate (D-GAP, 3) and pyruvate (4) under catalysis of DXP synthase (DXS). Subsequently, 2 is converted into 1 by the DXP reductoisomerase (DXR). Thereafter, 1 is transformed into isopentenyl diphosphate (IPP, 5) and dimethylallyl diphosphate (DMAPP, 6), the two universal building blocks for all the natural terpenoids (Scheme 1) [2] .Compound 1 is now regarded as the first committed intermediate of the MEP pathway. Up to now, a number of chemical syntheses of 1 have been established and this has been well documented [3] . Enzymatic procedures for the preparation of this compound, however, have not been well developed. The only reported methods that were suitable for the preparation of isotope labeled 1 were established by Hecht et al. [4] . There is not a straightforward way to prepare unlabeled 1.
In one of our early papers we reported a chemo-enzymatic way to prepare 2 directly from 3 and commercial 4 [5] . Now we extend this method to the preparation of 1 by supplementing DXR and NADPH to the reaction mixture to provide a straightforward route for the enzymatic synthesis of 1. Furthermore, in order to fully remove the residue 2 that was not able to be totally converted to 1 by DXR [6] , we set up a specific two-step method to purify the product and 1 was obtained free from 2 with a yield of around 60% and in high purity (>95% as determined by 1 H NMR).
As mentioned above, the method reported herein utilizes 3 and 4 as starting materials. Although 3is also commercially available, it is either racemic or expensive. Thus we prefer to prepare it by ourselves not only because the improved protocol could produce 3 in its enantiomerically pure form in a yield of more than 80%, but also because the whole procedure is economically favorable [5] . The crude product of the preparation contained equal amounts of 3 and glycolic acid and we found that it could be directly used to synthesize2 without further workup. Therefore, we also utilized the mixture to prepare 1. Moreover, to assure the maximum conversion of 2, a high concentration of DXR (1 mg/mL) and a little excess of NADPH were added. The other conditions were the same as those optimized. Based on the above discussion, we selected the following conditions to obtain a maximum production of 1: the molar ratio of4 to 3 was 2:1, the concentrations of DXS and DXR were both 1mg/mL, the pH of the reaction buffer was 7.5, and the incubation time and temperature were 3 h and 37 o C, respectively.
Purification of the product was achieved using the protocol developed for the isolation of 2 at the beginning [5] . However, unfortunately, the negative mode ESI-MS of the product showed that it contained both the intermediate 2 (m/z 213, [M-H] -, less than 10%) and the target molecule 1 (m/z 215, [M-H] -, more than 90%). Repeated DEAE Sephadex isolation of the oil followed by Dowex 50w × 8 resin treatment could not remove the residue 2. We then tried several other ways to separate the two phosphates, for example with a silica gel column using a mixture of i-propanol-conc NH 4 OH-H 2 O (6:3:1 (v/v/v)) as a developing solvent [7] or with BaCl 2 as a precipitating reagent to precipitate separately these two compounds. However, neither method worked so well. We then thought that it could be possible to use the structural difference of these two compounds to remove 2 from 1 since 2 is a sugar phosphate holding a carbonyl group, while 1 is a sugar alcohol phosphate. We checked the idea to see whether it worked. After DEAE Sephadex column separation, the combined fractions containing the reaction products and ammonium formate were evaporated under reduced pressure to a small volume, frozen with liquid nitrogen and then lyophilized. The pale yellow solid thus generated was extracted with methanol and the supernatants were pooled and evaporated under reduced pressure to dryness. A white powder was obtained and analyzed, the ESI-MS of which showed that it contained only 1 (m/z 215, [M-H]-); no 2 could be detected. The methanol insoluble yellow part might be some kind of polymer resulting from the reaction between the carbonyl group of 2 and ammonium formate during lyophilization.
In conclusion, we have established an attractive one-pot enzymatic procedure to synthesize MEP (1) and a specific two-step method to purify the product. Compound 1 could be acquired in a yield of about 60% and in high purity (>95%) without contamination by2. Although this procedure leads to a little loss of 2, it largely simplifies the reaction mixture compared with the methods reported in [4] and thus makes the preparation easier to handle. The purified yield of unlabeled 1 is on the same level as or even better than that of the reported methods [4] .
Experimental
General: Plasmid pFMH30 for the synthesis of recombinant DXS of Rhodobacter capsulatus was a kind gift from Prof. C. Dale Poulter, Chemistry Department, University of Utah. The bacterial strain E. coli BL21 (DE3) was from the stock of our institute, and the plasmid pET15b-DXR was constructed in our preliminary work [8] . DEAE Sephadex A-25 was from Sigma, Ni-NTA Agarose resin from Qiagen, sodium pyruvate, ThPP and NADPH from Sangon Biotech, and D-GAP was from our preliminary work [5] . All other chemicals were of analytical grade. 1 H-NMR and 31 P NMR were recorded on a Varian-Inova 400 NMR spectrometer; MS were determined on a Thermo-Fisher LTQ XL mass spectrometer.
Preparation of DXS and DXR:
The preparation of DXS and DXR followed the published procedures [8, 9] . The yields of DXS and DXR were 10 mg and 14 mg per L medium, respectively.
Preparation and purification of MEP:
To a soln. containing 100 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 2 mM ThPP, 2 mM dithiothreitol, purified 3 (100 mg, 0.59 mmol) or crude 3 (145 mg, containing 45 mg of glycolic acid), sodium pyruvate (130.3 mg, 1.18 mmol), and NADPH (540 mg, 0.65 mmol) were added. After the pH of the mixture was adjusted to 7.5 with 2 M NaOH, the reaction was initiated by addition of 1.5 mg DXS of R. capsulatus and 1.5 mg DXR of E. coli and incubated at 37 o Cfor 3 h(total volume 1.5 mL). After incubation, the reaction mixture was directly applied to a 1.5 × 18 cm column of DEAE Sephadex A-25, which was pretreated with 80 mL of 0.06 M HCOONH 4 (pH 8.0) at 4 o C. The product was then eluted with a linear gradient of 0.06 M-0.6 M HCOONH 4 (0.06 M and 0.6 M, pH 8.0, 250 mL each, flow rate 2 mL/min, 15 mL per fraction). The fractions containing MEP and minor DXP were combined and concentrated under reduced pressure to a small volume (ca. 15 mL), frozen with liquid nitrogen and then lyophilized. The pale yellow solid thus generated was extracted 3 times with methanol (3 × 5 mL) and the supernatants were pooled and evaporated under reduced pressure to dryness. MEP was obtained as a white powder (72.3 mg, yield: 57.4%) with a purity of 95% (determined by 1 H-NMR). 
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